Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Biogen Inc. (BIIB) had Beginning Cash of $3.01B for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$2.74B
Net Income	$97.50M
Cost of Goods Sold	$776.90M
Gross Profit	$1.96B
Operating Expenses	$2.59B
Operating Income	$150.90M
Non-Operating Income/Expense	$-18.50M
Pre-Tax Income	$132.40M
Normalized Pre-Tax Income	$132.40M
Income after Taxes	$97.50M
Income from Continuous Operations	$97.50M
Consolidated Net Income/Loss	$97.50M
Normalized Income after Taxes	$97.50M
EBIT	$150.90M
EBITDA	$589.80M
Weighted-Average Shares Outstanding (Basic)	147.70M
Weighted-Average Shares Outstanding (Diluted)	148.70M
Earnings per Share (EPS) (Basic)	$0.66
Earnings per Share (EPS) (Diluted)	$0.66
Balance Sheet Financials
Current Assets	$7.31B
Property, Plant, and Equipment	$2.99B
Long-Term Assets	$24.78B
Total Assets	$32.09B
Current Liabilities	$3.92B
Long-Term Debt	$7.29B
Long-Term Liabilities	$9.32B
Total Liabilities	$13.24B
Common Equity	$18.85B
Tangible Shareholders Equity	$-1.66B
Shareholders Equity	$18.85B
Common Shares Outstanding	147.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.09B
Cash Flow from Investing Activities	$-4.05B
Cash Flow from Financial Activities	$1.25B
Beginning Cash	$3.01B
End Cash	$1.28B
Increase/Decrease in Cash	$-1.72B
Stock-Based Compensation	$161.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.28
Debt to Equity Ratio	0.43
Gross Margin	71.60%
Operating Margin	5.52%
EBIT Margin	5.52%
EBITDA Margin	--
Pre-Tax Profit Margin	4.84%
Profit Margin	3.56%
Free Cash Flow	$1.00B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.33
Receiveable Turnover	1.45
Days Sales in Receivables	62.03
Return on Equity	0.52%
Return on Tangible Equity	-5.88%
Return on Assets	0.30%
Return on Investments	0.37%
Book Value Per Share	$127.61
Free Cash Flow per Share	$6.74
Operating Cash Flow per Share	$7.36

Data from Zacks Investment Research, Inc.